A recent study conducted in Los Angeles reveals that habitual users of fentanyl have developed dramatically increased tolerance levels, rendering standard treatment protocols for opioid withdrawal less effective. The research, published in the journal Drug and Alcohol Dependence, underscores the growing challenges faced by medical professionals managing fentanyl addiction amid an erratic and potent street drug supply.
Researchers affiliated with Drug Checking Los Angeles collected and analyzed over 500 samples of illicit fentanyl along with interviews of 47 users between September 2023 and January 2026. The service allows individuals to voluntarily and anonymously test their drugs for adulterants. According to the study, typical users consume approximately one gram of product daily, equating to roughly 125 milligrams of pure fentanyl—a substance estimated to be at least 50 times more potent than heroin.
Morgan Godvin, a lead author and health services researcher at the University of California, Los Angeles, emphasized the severity of the users’ tolerance. She noted that the daily fentanyl dose used by routine consumers corresponds to about 1,250 hospital-administered doses of 100 micrograms given during and after surgery. Godvin highlighted that such quantities would be fatal in any other context, but have become commonplace among persistent fentanyl users.
The findings challenge current opioid addiction treatment regimens, which are largely based on models developed for heroin and prescription painkiller dependencies. Medications like buprenorphine and methadone, administered to alleviate withdrawal symptoms without causing euphoria, were designed for patients with lower opioid tolerances. As a result, clinicians are confronting situations where standard dosage guidelines fall short.
Chelsea L. Shoven, an associate professor at UCLA’s medical school and co-author of the study, urged clinicians to heed patients’ experiences of inadequate withdrawal management. Echoing this concern, Dr. Melissa Weimer, medical director of the addiction medicine consult service at Yale New Haven Hospital, described cases where fentanyl-dependent patients require significantly higher opioid doses—sometimes characterized as “horse- and elephant-sized”—to achieve stabilization. Dr. Weimer remarked that ten years ago, prescribing 40 milligrams of oxycodone for such patients would have been unthinkable.
The study also highlighted extreme variability in the purity of street fentanyl samples, with pure fentanyl content ranging from under one milligram to more than 650 milligrams within a single gram of powder. This inconsistency sharply increases the risk of overdose for users, as the amount ingested can differ substantially despite similar reported quantities.
Experts note that drug consumption patterns and supply characteristics vary regionally. In Los Angeles, where fentanyl appeared later than on the East Coast, inhalation is the primary route of administration, potentially contributing to slower absorption and higher tolerance. By contrast, injection is more common on the East Coast, leading to quicker drug uptake. Despite these differences, the unpredictability of fentanyl purity and the escalating tolerance among long-term users appear to be consistent trends nationwide.
The study's authors and addiction specialists advocate for updated treatment protocols that reflect the evolving realities of fentanyl use and aim to improve outcomes for patients grappling with this potent synthetic opioid.